Michael Boivin

CommPharm Consulting

SCHOLARLY PAPERS

2

DOWNLOADS

127

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Identification of Individuals at High Risk of Adverse Outcomes from COVID-19: A Systematic Review

Number of pages: 17 Posted: 16 Oct 2023
University of Exeter, CommPharm Consulting, University of Toronto - St. Michael’s Hospital, RESPIPLUS, University of British Columbia (UBC), McGill University, Canadian Heart Research Centre, McGill University - Meakins-Christie Laboratories, McGill University, University of Toronto - St. Michael’s Hospital, RESPIPLUS and Respiratory Epidemiology and Clinical Research Unit, Research Institute of McGill University Health Centre, McGill University, Montreal, Canada
Downloads 68 (712,386)

Abstract:

Loading...

high-risk COVID-19, high-risk populations, severe outcomes, COVID-19, mortality, hospitalization, respirology, immunology, cardiovascular disease, nephrology, neurology, endocrinology, preventative management, therapeutic management, COVID-19 risk factors

2.

Cannabidiol-Associated Hepatotoxicity: A Systematic Review and Meta-Analysis

Number of pages: 70 Posted: 18 Nov 2022
University of Toronto - Department of Public Health Sciences, Queen Mary University of London, Barts and The London School of Medicine and Dentistry, Blizard Institute, Wingate Institute of Neurogastroenterology, Centre for Neuroscience and Trauma, University of British Columbia (UBC) - Department of Medicine, Johns Hopkins University - Department of Psychiatry and Behavioral Sciences, University of British Columbia (UBC) - Department of Anesthesiology, Pharmacology and Therapeutics, CommPharm Consulting, University of British Columbia (UBC) - Department of Anesthesiology, Pharmacology and Therapeutics and University of British Columbia (UBC) - Department of Medicine
Downloads 59 (766,307)

Abstract:

Loading...

Cannabidiol, CBD, Liver Safety, Drug-Induced Liver Injury, Liver Enzymes, Adverse Drug Reaction